Last reviewed · How we verify
Chronic Escherichia coli Prostatitis
Approved treatments
- Noroxin
- Floxin
- Levaquin · Generic (originally Daiichi Sankyo/J&J)
Levofloxacin is a fluoroquinolone antibacterial agent. - Ofloxacine · Assistance Publique - Hôpitaux de Paris
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Chronic Escherichia coli Prostatitis patent landscape — cliff calendar, originator estates, attackable patents
- Chronic Escherichia coli Prostatitis treatment landscape brief
- Chronic Escherichia coli Prostatitis treatment updates RSS
Frequently asked questions about Chronic Escherichia coli Prostatitis
What drugs treat Chronic Escherichia coli Prostatitis?
Tracked treatments include Noroxin, Floxin, Levaquin, Ofloxacine.
What is the treatment for Chronic Escherichia coli Prostatitis?
Standard treatment for Chronic Escherichia coli Prostatitis includes Noroxin, Floxin, Levaquin, Ofloxacine. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Chronic Escherichia coli Prostatitis patent cliff · Chronic Escherichia coli Prostatitis CI report
- Treatment: Noroxin
- Treatment: Floxin
- Treatment: Levaquin · Generic (originally Daiichi Sankyo/J&J)
- Treatment: Ofloxacine · Assistance Publique - Hôpitaux de Paris
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing